|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.43 EGP | -5.81% |
|
-11.31% | -22.61% |
| Mar. 03 | Ibnsina Pharma Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Feb. 05 | Ibnsina Pharma(CASE:ISPH) added to EGX 30 Index | CI |
Ibnsina Pharma reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was EGP 33,949.33 million compared to EGP 22,264.5 million a year ago. Net income was EGP 213.66 million compared to EGP 172.58 million a year ago.
Basic earnings per share from continuing operations was EGP 0.17 compared to EGP 0.13 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -22.61% | 51.14M | |
| -32.21% | 15.27B | |
| -30.05% | 10.84B | |
| -28.54% | 6.06B | |
| +8.14% | 6.04B | |
| -11.41% | 5.86B | |
| -1.17% | 4.69B | |
| +52.19% | 4.29B | |
| -14.86% | 3.33B | |
| -6.93% | 3.01B |
IBNSINA PHARMA 
